Vienna, Austria,
2004-08-26 16:29
(5798 d 21:47 ago)

Posting: # 8
Views: 11,934

 Generic Dimenhydrinate Injection USP for Motion Sickness [BE/BA News]

The FDA approved on 24 June 2004 a new generic of dimenhydrinate (dimenhydrinate injection USP, made by American Pharmaceutical Partners, Inc.), an antiemetic indicated for the prevention and treatment of nausea, vomiting, or vertigo of motion sickness. It is the generic equivalent of Dramamine (made by Pfizer) and will be available in 50 mg/mL, 1 mL vials.

Manufacturing of dimenhydrinate injection had been discontinued since 2000 for reasons other than safety or efficacy.

Medscape members may follow this link:

Dif-tor heh smusma 🖖
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
 Admin contact
20,819 posts in 4,356 threads, 1,447 registered users;
online 28 (1 registered, 27 guests [including 10 identified bots]).
Forum time: 14:16 CEST (Europe/Vienna)

Statistics are no substitute for judgment.    Henry Clay

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz